Letrozol Pharmacare (Letrozole)

Letrozole works by selectively inhibiting the aromatase enzyme, which converts adrenal androgens into estrogens. By blocking this conversion, circulating estrogen levels fall, depriving estrogen‑dependent cancer cells of a key growth signal and thereby slowing tumor progression.

The exact dose of Letrozol Pharmacare is determined by the prescribing physician based on the patient’s clinical condition, renal and hepatic function, and treatment goals. In most clinical protocols, letrozole is administered once daily, but the prescriber sets the precise regimen.

Letrozol Pharmacare is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of fetal harm. It is also not recommended during breastfeeding because it may pass into breast milk and affect the infant.

To order Letrozol Pharmacare, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

The primary alternative to letrozole is another aromatase inhibitor, anastrozole. Both agents lower estrogen levels, but letrozole is often considered slightly more potent, while anastrozole may have a more favorable bone‑health profile in some patients. Choice depends on individual patient factors and physician judgment.

Letrozol Pharmacare should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original blister pack, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Letrozol Pharmacare is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their healthcare professional to maintain consistent absorption.

Serious risks include severe liver injury, osteoporotic fractures, deep vein thrombosis, pulmonary embolism, and cardiovascular events such as myocardial infarction. Patients should report any signs of liver dysfunction, unexplained bone pain, swelling of the limbs, or chest discomfort to their physician promptly.

Letrozol Pharmacare is contraindicated in pregnant women, individuals with known hypersensitivity to letrozole or any component of the formulation, and patients with severe liver impairment. Caution is also advised for those with a history of thromboembolic disease or uncontrolled cardiovascular conditions.